Growth Metrics

Vericel (VCEL) Shareholder's Equity (QoQ) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Vericel 1.69 Bn 1.55 Bn 49.27 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.45%
Dec 31, 2025 10.19%
Sep 30, 2025 4.91%
Jun 30, 2025 3.83%
Mar 31, 2025 1.21%
Dec 31, 2024 13.40%
Sep 30, 2024 5.97%
Jun 30, 2024 3.88%
Mar 31, 2024 3.52%
Dec 31, 2023 10.55%
Sep 30, 2023 2.74%
Jun 30, 2023 2.55%
Mar 31, 2023 0.89%
Dec 31, 2022 8.12%
Sep 30, 2022 1.73%
Jun 30, 2022 1.35%
Mar 31, 2022 1.19%
Dec 31, 2021 8.73%
Sep 30, 2021 3.76%
Jun 30, 2021 7.76%
Mar 31, 2021 4.43%
Dec 31, 2020 17.12%
Sep 30, 2020 6.54%
Jun 30, 2020 -2.59%
Mar 31, 2020 -0.58%
Dec 31, 2019 14.54%
Sep 30, 2019 9.54%
Jun 30, 2019 -14.08%
Mar 31, 2019 0.81%
Dec 31, 2018 8.21%
Sep 30, 2018 4.28%
Jun 30, 2018 332.76%
Mar 31, 2018 -7.12%
Dec 31, 2017 34.67%
Sep 30, 2017 19.78%
Jun 30, 2017 -9.87%
Mar 31, 2017 -37.25%
Dec 31, 2016 116.87%
Sep 30, 2016 -33.40%
Jun 30, 2016 -11.02%
Mar 31, 2016 -13.12%
Dec 31, 2015 -16.21%
Sep 30, 2015 -12.68%
Jun 30, 2015 -4.60%
Mar 31, 2015 -11.05%
Dec 31, 2014 -5.67%
Sep 30, 2014 1,256.70%
Jun 30, 2014 -26.11%
Mar 31, 2014 -3.21%
Dec 31, 2013 -21.33%
Sep 30, 2013 112.06%
Jun 30, 2013 -12.20%
Mar 31, 2013 -13.93%
Dec 31, 2012 -30.28%
Sep 30, 2012 -18.97%
Jun 30, 2012 4.67%
Mar 31, 2012 -67.48%
Dec 31, 2011 -16.25%
Sep 30, 2011 -9.84%